BRAF and colorectal carcinoma: Unfortunately, there are currently no data on the predictive value of TILs density in assessing the efficacy of immunotherapy in BRAF mutant CRC, but a higher density of TILs was found to be associated with a good prognosis regardless of BRAF mutation status [80, 81].